Osteoinductive pharmaceutical formulations
US5364839A · kind A · utility
44Cited by
14References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 1990 |
| Grant date | Nov 15, 1994 |
| Priority date | — |
| Expiry date | Jun 18, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Osteoinductive pharmaceutical formulations comprising antifibrinolytic agents such as epsilon amino acid caproic acid or other lysine analogues or serine protease inhibitors and cartilage and/or bone inductive proteins are disclosed. These formulations are useful in the treatment of cartilage and/or bone defects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.